IMV Inc IMVIQ

To be "positive"

[Breakthorough1]

This intellectual property (66 issued patents and 77 pending in 22 patent families), accompanied with the good clinical results we all expect they have (even if they have not shown all of them...) should be worth much more money than the $25mill debt. What is going to happen in this stressing situation, who knows.

[prosciutto]

what is going to happen: litigation, maybe criminal

[Breakthorough1]

February 13th: "Overall Response Rate (“ORR”) will be communicated when the totality of stage one data are available for definitive assessment." The "will" can envelop it as a forward-looking statement (though to a level in which communication is just impossible). But not the "when". The "will" depends on the "when". And the "wen", once

[Breakthorough1]

Meaning: there is a causal relation between the "when" and the "will": the "will" is going to be a fact once the "when" is here. If they didn't lie, there were 23 patients enrolled the 16th of March, and the expectation of enrolling not only 7 more (to reach the 30 of Stage1), but some extra patients, as they said the 16th of March ("In the next

[Breakthorough1]

So. They don't disclose the data because: A) They are good but a good transaction, also for shareholders, requires not to disclose them. B) They are 1) good or 2) bad but they don't disclose them 1) in the benefit of someone (not shareholders) or 2) to avoid being caught lying about how the data were trending (16th March: "We have enough data in hand to be confident about the